|
Diabetes News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
Financial Interests Should Be Clearer To Increase Trust In Science Suggests Study Of Research Behind Anti Diabetes Drug
A new US study published this week that investigated the research behind the anti-diabetes drug rosiglitazone (GlaxoSmithKline's Avandia) found that nearly all the scientific authors who provided results in favour of the drug had financial relationships with pharmaceutical companies, and while this may not prove industry's interests influenced the research, it sugge...
-
CPEX Pharmaceuticals Announces Preliminary Results From Its Phase 2a Clinical Trial Of Nasulin™
CPEX Pharmaceuticals Inc. (NASDAQ: CPEX) reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™...
-
Call For More Nutrition Training For Doctors, UK
Nutrition needs to become a more important part of doctors' training as leading experts claim that current provision is "patchy"...
-
Study Finds Selenium Protects Men Against Diabetes
The role of selenium in diabetes has been controversial, with some studies suggesting that it raises diabetes risk and others finding that it is protective. Now, research published in BioMed Central's open access journal Nutrition and Metabolism, has shown that, for men, high plasma selenium concentrations are associated with a lower occurrence of dysglycemia...
-
Are You Surrounded By Risk? - American Diabetes Association
To combat the growing diabetes epidemic, the American Diabetes Association is asking Americans -- "What will you do to Stop Diabetes? Know your risk." On March 23, the 22nd annual American Diabetes Association Alert Day(SM), the Association is encouraging people to join the Stop Diabetes movement by taking the Diabetes Risk Test (at stopdiabetes...
-
Diabetes Patients' Lives May Be Shorter If They Have Difficulty Trusting And Reaching Out To Others
Mistrust can exact a high toll. Being overly cautious or dismissive in relating to people, researchers are learning, may shorten the lives of people with diabetes. Diabetes patients who have a lower propensity to reach out to others have a higher mortality rate than those who feel comfortable seeking support. These are the findings of a five-year study reported by Dr...
-
Educational Events Planned For Diabetes Alert Day In Alabama
Diabetes is one of the most significant health issues facing Alabama today and is expected to remain so in the years ahead. Two events are planned to educate and inform the public about diabetes on March 23, Diabetes Alert Day...
-
Device Manages Care Online For Chronic Disease Patients
The Cleveland Plain Dealer: A pilot project at the Cleveland Clinic that monitored 250 patients with chronic diseases showed patients were able to increase the number of days between visits. The study used a medical device that shared daily patient data online with doctors and nurses and found that patients better managed their care using the system...
-
'Worried Well' Cost NHS Time And Money - Diabetes UK
Approximately £2bn of healthcare money is wasted on adults of working age seeing their GP for a minor ailment. Almost a fifth of GP appointments are spent seeing patients for back pain, indigestion and other common complaints including coughs, colds and headaches. This is time taken away from patients who are in most need, such as people with diabetes...
-
'Walk The Extra Mile' For Diabetes UK
Do you like to have fun outdoors? Do you want to raise much-needed funds for diabetes research? Then why not take part in 'Walk the extra mile', a series of walks organised by Diabetes UK taking place across the UK, throughout the summer (and beyond)...
-
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L or higher) and low levels of high-density lipoprotein cholesterol (HDL-C, 34 mg/dL or 0.88 mmol/L or lower). This is achieved by adding fenofibrate to simvastatin...
-
Search For New Diabetes And Heart Disease Treatments Unresolved
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford...
|
